V
LIVE

Serial Number

79429235

Owner

VITEX PHARMACEUTICALS PTY LTD

Attorney

Stephen Jadie Coates

Filing Date

Jun 5, 2025

Add to watchlist:

No watchlists yet
View on USPTO

V Trademark

Serial Number: 79429235 • Registration: 8237750

V is a trademark filed by VITEX PHARMACEUTICALS PTY LTD on June 5, 2025. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

VITEX PHARMACEUTICALS PTY LTD (2 trademarks)

PO BOX 321

Entity Type: 98

Trademark Details

Filing Date

June 5, 2025

Registration Date

May 5, 2026

Published for Opposition

March 17, 2026

Goods & Services

Laboratory research in the field of complementary medicine, namely vitamins, minerals, nutritional supplements, prescription and non-prescription medicines; pharmaceutical research services; research and development of new products for others; research and development of new products; research to develop new products; research laboratories, namely, laboratory research in the field of complementary medicine, namely vitamins, minerals, nutritional supplements, prescription and non-prescription medicines; research relating to medicine; research relating to pharmaceuticals; scientific research; scientific research into the development of new products; graphic design services; laboratory analysis services in the field of complementary medicine, namely vitamins, minerals, nutritional supplements, prescription and non-prescription medicines; laboratory services being research in the field of complementary medicine, namely vitamins, minerals, nutritional supplements, prescription and non-prescription medicines; laboratory testing of materials; material testing; materials evaluation and testing; microbiological testing for research purposes; product testing; quality control product testing; product quality testing; testing of materials; testing of new products; testing of products; product failure analysis services; new product design; new product development; product quality evaluation; scientific evaluation of product development and design; technological monitoring and inspection of vitamins, minerals, nutritional supplements, prescription and non-prescription medicines; quality control for others; quality control of goods; quality control services for others for certifying product quality; development of new products

Materials treatment in the nature of coating of tablets, granules and powders; custom manufacture of vitamins, minerals, nutritional supplements, prescription and non-prescription medicines

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
May 28, 2026 NREP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 5, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 5, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 17, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Mar 12, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 11, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 25, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 24, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 19, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 17, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 16, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 16, 2026 TROA
REFUSAL PROCESSED BY IB
Dec 25, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 8, 2025 RFCS
REFUSAL PROCESSED BY MPU
Dec 8, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 30, 2025 RFCR
NON-FINAL ACTION WRITTEN
Oct 29, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 24, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 8, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 31, 2025 REPR